• Batycky exits Acorda to head up new biotech fiercebiotech
    August 15, 2018
    Acorda Therapeutics’ chief technology officer, Rick Batycky Ph.D., is leaving the company next week after four years in the role to head up his own operation.
PharmaSources Customer Service